Rani Therapeutics Holdings, Inc. ( NASDAQ:RANI – Get Rating ) major shareholder South Cone Investments Limited bought 3,900 shares of the firm's stock in a transaction on Thursday, March 2nd. The stock was bought at an average price of $6.31 per share, with a total value of $24,609.00. Following the completion of the purchase, the insider now owns 6,769,555 shares of the company's stock, valued at $42,715,892.05. The purchase was disclosed in a legal filing with the SEC, which is available at this link .

https://www.dailypolitical.com/2023/03/06/insider-buying-rani-therapeutics-holdings-inc-nasdaqrani-major-shareholder-acquires-3900-shares-of-stock.html

#dailypolitical